Patent applications published 31 August 2011
Selected patent applications from the weekly European Patents Bulletin
- Methods and compsns for diagnosis and prognosis of renal injury and renal failure
Astute Medical 2361018*
- Use of an anti-VEGF antibody in combination with chemotherapy for treating breast cancer
F Hoffmann-La Roche 2361085*
- Treatment of oncological diseases
Sigma-Tau Industrie Farmaceutiche Riunite 2361086*
- Anti-inflammatory compounds and compsns thereof
GlaxoSmithKline 2361087*
- Method of inducing cleavage of amyloid precursor protein to form a novel fragment
The Regents of the University of California; Zenyaku Kogyo 2361088*
- Compsns and methods for the treatment of altered-synuclein function
Parkinson’s Institute; The Hospital for Sick Children; Neuraltus Pharmaceuticals 23610789*
- Compsns for treating centrally mediated nausea and vomiting
Helsinn Healthcare 2361090*
- Bile acids and biguanidines as protease inhibitors for preserving the integrity of peptides in the gut
Axcess 2361091*
- Health care
Rozmanith, Anthony; Rozmanith, Jolam 2361092*
- Compsns and methods for regulating collagen and smooth muscle action expression by Serpine2
Five Prime Therapeutics; Centocor Research and Development 2361093*
- Combination vaccine with whole cell pertussis
Panacea Biotec 2361094*
- Antagonists of IL-6 to raise albumin and/or lower CRP
Alder Biopharmaceuticals 2361095*
- Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue and/or fever
Alder Biopharmaceuticals 2361096*
- Na/K-ATPase-derived peptide SRC inhibitors and ouabain antagonists and uses thereof
The University of Toledo 2361097*
- Compsns and methods for delivering a substance to a biological target
The General Hospital Corp 2361098*
- Method for manufacturing a methylmercaptopropionaldehyde and methionine using renewable raw materials
Arkema France 2361239*
- Method for manufacturing a biomass-derived methyl methylacrylate
Arkema France 2361240*
- Method for synthesis of an omega-amino acid or ester starting from a monounsaturated fatty acid or ester
Arkema France 2361241*
- Oxidase inhibitors and their use
Oryzon Genomics 2361242*
- Haloalkyl containing compounds as cysteine protease inhibitors
Virobay 2361243*
- A process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines
Council of Scientific and Industrial Research 2361244*
- Hybrid -ionone and curcumin molecules as anti-cancer agents
TRT Pharma 2361245*
- Oxopiperidinyl and pyranyl sulphonamides as AMPA potentiators
Pfizer 2361246*
- Flupirtine hydrochloride maleic acid cocrystal
Bionevia Pharmaceuticals 2361247*
- Heteroaryl compounds and uses thereof
Avila Therapeutics 2361248*
- System and method for controlling growth of micro-organisms with biominated furanones
Syracuse University 2361249*
- Novel polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl)-2H-pyridazin-3-one dihydrogenphopshate and processes of manufacturing thereof
Merck Patent 2361250*
- Novel compounds useful for the treatment of degenerative and inflammatory diseases
Galapagos 2361251*
- 3H-imidazo [4,5-C]pyridine-6-carboxamides as anti-inflammatory agents
Boehringer Ingelheim International 2361252*
- Compounds
Selcia 2361253*
- RAF inhibitors and their uses
ArQule 2361254*
- Cyclohexenyl nucleic acid analogues
Isis Pharmaceuticals 2361256*
- Triacylglycerol purification by a continuous regenerable adsorbent process
The Dallas Group of America 2361257*
- A nonapeptide with anti-tumour activity
Lytix Biopharma 2361258*
- Efficient transport into white blood cells
Xigen 2361259*
- Novel transporter constructs and transporter cargo conjugate molecules
Xigen 2361260*
- Cells, nuclein acid constructs, cells comprising said constructs and methods utilising said cells in the treatment of diseases
Cellerix 2361261*
- Tetranectin trimerising module truncation variants
Anaphore 2361262*
- Use of anti-CS1 antibodies for treatment of rare lymphomas
Abbott Biotherapeutics; Cleveland Clinic 2361263*
- Gypsum based formulations
BPB 2361264*
- Compsns and methods comprising a subtilisin variant
Danisco 2361300*
- Apparatus and methods for processing biological material
Baxter International; Baxter Healthcare 2361301*
- Active microfluidic system for in vitro culture
Nanopoint 2361302*
- An isolated multipotent mesenchymal stem cell from human adult glomeruli (HGL-MSC), a method of preparing thereof in the regenerative medicine of the kidney
Fresenius Medical Care Deutschland 2361303*
- Novel method
GlaxoSmithKline Biologicals 2361304*
- Nucleic acid compounds for inhibiting BIRC5 gene expression and uses thereof
Marina Biotech 2361305*
- Compsns and methods for selective inhibition of pro-angiogenic isoforms
OPKO Ophthalmics 2361306*
- Pesticidal genes from brevibacillus and methods for their use
Athenix Corp 2361307*